Novo Nordisk A/S (NVO) vs Roche Holding AG (RHHBY)
A side-by-side comparison of Novo Nordisk A/S and Roche Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 27, 2026. Differences are shown without an overall score or investment verdict.
NVO
Novo Nordisk A/S
$46.26HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
RHHBY
Roche Holding AG
$56.39HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
Total return — NVO vs RHHBY
growth of $100 · dividends reinvested · last 10yNVO +142.9% (+9.3%/yr)RHHBY +158.1% (+9.9%/yr)RHHBY compounded faster over this window
NVO RHHBY
NVO vs RHHBY: by the numbers
- •RHHBY is the larger company ($359.46B vs $205.42B market cap).
- •NVO trades at the lower trailing earnings multiple (11.63 vs 16.15 P/E), one valuation lens rather than an overall verdict.
- •NVO converts more revenue to profit (35.33% vs 20.33% net margin).
- •NVO grew revenue faster over the past five years (19.76% vs 3.94% CAGR).
- •RHHBY pays the higher dividend yield (2.75% vs 1.23%).
Metrics side by side
Valuation
| Metric | NVO | RHHBY |
|---|---|---|
| P/E ratio | 11.63 | 16.15 |
| Forward P/E | N/A | 22.83 |
| P/S ratio | 4.10 | 4.53 |
| P/B ratio | 6.21 | 9.06 |
| EV / EBITDA | 8.54 | 14.21 |
| FCF yield | 3.56% | 4.69% |
Profitability
| Metric | NVO | RHHBY |
|---|---|---|
| Gross margin | 80.64% | 73.73% |
| Operating margin | 43.10% | 29.16% |
| Net margin | 35.33% | 20.33% |
| ROE | 53.50% | 38.06% |
| ROIC | 30.21% | 19.71% |
Dividends
| Metric | NVO | RHHBY |
|---|---|---|
| Dividend yield | 1.23% | 2.75% |
| Payout ratio | 16.01% | 60.81% |
Growth (annualized)
| Metric | NVO | RHHBY |
|---|---|---|
| Revenue CAGR (5Y) | 19.76% | 3.94% |
| EPS CAGR (5Y) | 19.59% | 1.54% |
| FCF CAGR (5Y) | -1.45% | 5.54% |
| Total return CAGR (5Y) | -0.29% | 5.84% |
Frequently asked
- Which has the lower trailing P/E, NVO or RHHBY?
- NVO has the lower trailing P/E: NVO trades at 11.63 and RHHBY at 16.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, NVO or RHHBY?
- Over the past five years, NVO grew revenue faster — NVO at a 19.76% CAGR versus RHHBY at 3.94%.
- Does NVO or RHHBY pay a bigger dividend?
- NVO yields 1.23% and RHHBY yields 2.75% based on trailing dividends and the latest price.
- Is NVO or RHHBY more profitable?
- NVO runs the higher net margin — NVO at 35.33% versus RHHBY at 20.33%.
- How have NVO and RHHBY total returns compared?
- Over the past 10 years, NVO delivered 9.40% and RHHBY delivered 9.59% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Novo Nordisk A/S P/E ratioRoche Holding AG P/E ratioNovo Nordisk A/S dividend yieldRoche Holding AG dividend yieldNovo Nordisk A/S ROERoche Holding AG ROENovo Nordisk A/S operating marginRoche Holding AG operating marginNovo Nordisk A/S revenue growthRoche Holding AG revenue growthNovo Nordisk A/S free cash flowRoche Holding AG free cash flow
Novo Nordisk A/S & Roche Holding AG appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 27, 2026.